Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease

被引:3
|
作者
Mitchell, Jonathan [1 ]
Herrick-Reynolds, Kayleigh [2 ]
Motter, Jennifer D. [1 ]
Teles, Mayan [1 ]
Kates, Olivia [3 ]
Sung, Hannah [1 ]
Chen, Po-Hung [3 ]
King, Elizabeth [1 ]
Cameron, Andrew [1 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Surg, 720 Rutland Ave, Ross 765, Baltimore, MD 21205 USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 09期
基金
美国国家卫生研究院;
关键词
FOLLOW-UP; PREDICTORS; ABSTINENCE; RELAPSE;
D O I
10.1097/TXD.0000000000001532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT. Methods. A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email. Results. Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."Conclusions. More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Recidivism in Liver Transplant Recipients With Alcoholic Liver Disease: Analysis of Demographic, Psychosocial, and Histology Features
    Satapathy, Sanjaya K.
    Eason, James D.
    Nair, Satheesh
    Dryn, Oleksandra
    Sylvestre, Pamela B.
    Kocak, Mehmet
    Vanatta, Jason M.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 (05) : 430 - 440
  • [42] Alcohol and Substance Use in Liver Transplant Patients
    DiMartini, Andrea
    Crone, Catherine
    Dew, Mary Amanda
    CLINICS IN LIVER DISEASE, 2011, 15 (04) : 727 - +
  • [43] Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score
    Lee, Brian P.
    Vittinghoff, Eric
    Hsu, Christine
    Han, Hyosun
    Therapondos, George
    Fix, Oren K.
    Victor, David W.
    Dronamraju, Deepti
    Im, Gene Y.
    Voigt, Michael D.
    Rice, John P.
    Lucey, Michael R.
    Eswaran, Sheila
    Chen, Po-Hung
    Li, Zhiping
    Maddur, Haripriya
    Terrault, Norah A.
    HEPATOLOGY, 2019, 69 (04) : 1477 - 1487
  • [44] Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients
    Erard, Domitille
    Villeret, Francois
    Chouik, Yasmina
    Guillaud, Olivier
    Scoazec, Jean-Yves
    Caussy, Cyrielle
    Disse, Emmanuel
    Boillot, Olivier
    Hervieu, Valerie
    Dumortier, Jerome
    LIVER INTERNATIONAL, 2024, 44 (02) : 422 - 432
  • [45] Prognostic Factors in Alcohol-associated Liver Disease Patients Presenting With First Evidence of Ascites
    Fahoum, Khalid
    Shen, Nicole T.
    Basu, Elora
    Lee, Jihui
    Kaplan, Alyson
    Salajegheh, Annaheta
    Rosenblatt, Russell
    Jesudian, Arun
    Lucero, Catherine
    Fortune, Brett
    Safford, Monika
    Brown, Robert S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (02) : 200 - 206
  • [46] Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease
    Addolorato, Giovanni
    Ponziani, Francesca R.
    Dionisi, Tommaso
    Mosoni, Carolina
    Vassallo, Gabriele A.
    Sestito, Luisa
    Petito, Valentina
    Picca, Anna
    Marzetti, Emanuele
    Tarli, Claudia
    Mirijello, Antonio
    Zocco, Maria Assunta
    Lopetuso, Loris R.
    Antonelli, Mariangela
    Rando, Maria M.
    Paroni Sterbini, Francesco
    Posteraro, Brunella
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    LIVER INTERNATIONAL, 2020, 40 (04) : 878 - 888
  • [47] Alcohol use disorder and liver transplant: new perspectives and critical issues
    Gitto, Stefano
    Aspite, Silvia
    Golfieri, Lucia
    Caputo, Fabio
    Vizzutti, Francesco
    Grandi, Silvana
    Patussi, Valentino
    Marra, Fabio
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (04) : 797 - 810
  • [48] Assessment and Evaluation of Alcohol Use Disorder in Liver Transplant
    Branagan, William T.
    Norvell, J. P.
    TRANSPLANTATION, 2024, 108 (03) : 654 - 661
  • [49] Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation
    Giard, Jeanne-Marie
    Dodge, Jennifer L.
    Terrault, Norah A.
    LIVER TRANSPLANTATION, 2019, 25 (09) : 1310 - 1320
  • [50] Selective use of liver transplantation for severe alcohol-associated hepatitis
    Ayyala-Somayajula, Divya
    Han, Hyosun
    Terrault, Norah A.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (03) : 175 - 184